Facial nerve injury
is a common clinical condition that leads to
disfigurement and emotional distress in the affected individuals,
and the recovery presents clinical challenges. Tissue engineering
is the standard method to repair nerve defects. However, nerve regeneration
is still not satisfactory because of poor neovascularization after
implantation, especially for the long-segment nerve defects. In the
current study, we aimed to investigate the potential of chitosan tubes
inoculated with stem cell factor (SCF) and dental pulp stem cells
(DPSCs) in facial nerve-vascularized regeneration. In the in vitro
experiment, DPSCs were isolated, cultured, and then identified. The
optimal concentration of SCF was screened by CCK8. Cytoskeleton and
living-cell staining, migration, CCK8 test, and neural differentiation
assays were performed, revealing that SCF promoted the biological
activity of DPSCs. Surprisingly, SCF increased the neural differentiation
of DPSCs. The migration and angiogenesis experiments were carried
out to show that SCF promoted the angiogenesis and migration of human
umbilical vein endothelial cells (HUVECs). In the facial nerve, 7
mm defects of New Zealand white rabbits, hematoxylin–eosin
(HE), immunohistochemistry, toluidine blue staining, and transmission
electron microscopy observation were performed at 12 weeks postsurgery
to show more nerve fibers and better myelin sheath in the SCF + DPSC
group. In addition, the whisker movements, Masson’s staining,
and western blot assays were performed, demonstrating functional repair
and that the expression level of CD31 protein in the group SCF + DPSCs
was relatively close to that in the group Autograft. In summary, chitosan
tubes inoculated with SCF and DPSCs increased neurovascularization
and provided an effective method for repairing facial nerve defects,
indicating great promise for clinical application.